# A Trial of HRS-7450 in Chinese Healthy Volunteers

> **NCT06087094** · PHASE1 · UNKNOWN · sponsor: **Fujian Shengdi Pharmaceutical Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Cerebral Stroke

## Interventions

- **DRUG:** HRS-7450 ；Placebo

## Key facts

- **NCT ID:** NCT06087094
- **Lead sponsor:** Fujian Shengdi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087094, "A Trial of HRS-7450 in Chinese Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06087094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*